As of 2026-10-25, the Relative Valuation of Antares Pharma Inc (ATRS) is 7.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 41.6%.
The range of the Relative Valuation is 7.58 - 8.35 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 22.7x - 25.0x | 23.8x |
| Fair Price | 7.58 - 8.35 | 7.92 |
| Upside | 35.6% - 49.3% | 41.6% |
| Date | P/E |